Headlands Technologies’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Buy |
62,400
+57,761
| +1,245% | +$527K | 0.07% | 279 |
|
|
2025
Q1 | $36.9K | Buy |
+4,639
| New | +$36.9K | ﹤0.01% | 761 |
|
|
2024
Q3 | – | Sell |
-3,916
| Closed | -$42.5K | – | 1484 |
|
|
2024
Q2 | $42.5K | Buy |
3,916
+2,782
| +245% | +$30.2K | ﹤0.01% | 798 |
|
|
2024
Q1 | $21.3K | Buy |
+1,134
| New | +$21.3K | 0.01% | 896 |
|
|
2023
Q3 | – | Sell |
-2,442
| Closed | -$115K | – | 1164 |
|
|
2023
Q2 | $115K | Buy |
+2,442
| New | +$115K | 0.04% | 366 |
|